Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

Divert Converting Food Waste to Renewable Energy Under $1B Pact With Enbridge

Ryan Begin, Divert's CEO and co-founder, joined Cheddar News after the company recently received $1 billion infrastructure development agreement with Enbridge to support its efforts to protect the value of food.

Applebees, IHOP Parent Dine Brand Adds Fuzzy’s Taco Shop to Portfolio

John Peyton, CEO, of Dine Brands, parent company of IHOP and Applebee's, joined Cheddar News to discuss the company's latest earnings results and venture into fast casual with the acquisition of Fuzzy’s Taco Shop.

Mortgage Demand At Lowest Level In 30 Years

Mortgage demand reached its lowest level in about 30 years, as high borrowing costs kept potential buyers away.

Delta Pilots Agree on New 4-Year Contract With Raises

Delta Air Lines pilots voted in favor of a new four-year contract that will grant them raises.

DNA of Four Former Presidents to Be Launched Into Deep Space

The DNA of four former presidents — and some sci-fi greats — is set to be blasted off into the cosmos as part of the ultimate memorial.

A Look Behind the Current Wedding Boom

There were a record 2.6 million weddings in 2022, which is up from 1.9 million in 2021 and 1.3 million in 2020, according to a report from The Knot, a wedding planning agency.

Cheddar Afternoon News Briefings of March 1st

Cheddar Morning News Briefings

Stocks Slip as Stubborn Inflation Raises Rate Expectations

Most stocks marched lower Wednesday as stubbornly sticky inflation has Wall Street bracing for interest rates to stay higher for longer.

Eli Lilly Slashes Price of Insulin, Caps Monthly Cost at $35

In line with a Biden administration proposal, pharmaceutical giant Eli Lilly is cutting the price of its most commonly prescribed insulins by 70 percent and capping out-of-pocket costs at $35 or less per month.

Demand for Mortgage Applications Falls to 28-Year Low

Demand for mortgage loan applications fell 5.7 percent in the last week of February, according to a survey from the Mortgage Bankers Association (MBA).

Load More